TD Cowen Reiterates Buy Rating on Ascendis Pharma (ASND)
Tweet Send to a Friend
TD Cowen analyst Yaron Werber reiterated a Buy rating and $325.00 price target on Ascendis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
